Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
110
archived clinical trials in
Genital Herpes

A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Status: Enrolling
Updated:  12/1/2017
Clinical Research Facility
mi
from
Albuquerque, NM
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Status: Enrolling
Updated: 12/1/2017
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Status: Enrolling
Updated:  12/1/2017
Clinical Research Facility
mi
from
Portland, OR
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Status: Enrolling
Updated: 12/1/2017
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Status: Enrolling
Updated:  12/1/2017
Clinical Research Facility
mi
from
Philadelphia, PA
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Status: Enrolling
Updated: 12/1/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Status: Enrolling
Updated:  12/1/2017
Clinical Research Facility
mi
from
Arlington, TX
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Status: Enrolling
Updated: 12/1/2017
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Status: Enrolling
Updated:  12/1/2017
Clinical Research Facility
mi
from
Houston, TX
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Status: Enrolling
Updated: 12/1/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Status: Enrolling
Updated:  12/1/2017
Clinical Research Facility
mi
from
Salt Lake City, UT
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Status: Enrolling
Updated: 12/1/2017
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Status: Enrolling
Updated:  12/1/2017
Clinical Research Facility
mi
from
Annandale, VA
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Status: Enrolling
Updated: 12/1/2017
Clinical Research Facility
mi
from
Annandale, VA
Click here to add this to my saved trials
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Status: Enrolling
Updated:  12/1/2017
Clinical Research Facility
mi
from
Seattle, WA
A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Status: Enrolling
Updated: 12/1/2017
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Valacyclovir Caplets Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
PRACS Institute, Ltd.
mi
from
Fargo, ND
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Valacyclovir Caplets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
PRACS Institute, Ltd.
mi
from
Fargo, ND
Click here to add this to my saved trials
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Valacyclovir Caplets Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
PRACS Institute, Ltd.
mi
from
Fargo, ND
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Valacyclovir Caplets Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
PRACS Institute, Ltd.
mi
from
Fargo, ND
Click here to add this to my saved trials